Table 1

Summary of adult elective first ever registrations for a liver only transplant: 1 January 2006–31 December 2017

VariablesSWLUKCH (Ex. SWLU)National (Ex. KCH and SWLU)SWLU versus KCH (P value)* (Ex. SWLU)SWLU versus national (P value)* (Ex. KCH and SWLU)
Patients (n)21516146662
SexMale149 (69%)1071 (66%)4375 (66%)0.40.3
Female66 (31%)543 (34%)2287 (34%)
EthnicityWhite208 (97%)1386 (86%)5909 (89%)<0.0001<0.0001
Non-white7 (3%)228 (14%)753 (11%)
IndicationCancers18 (8%)116 (7%)493 (7%)0.40.7
HCV34 (16%)228 (14%)944 (14%)
ALD73 (34%)426 (26%)2003 (30%)
HBV6 (3%)73 (5%)179 (3%)
PSC17 (8%)140 (9%)668 (10%)
PBC13 (6%)125 (8%)607 (9%)
AID19 (9%)180 (11%)565 (9%)
Metabolic21 (10%)176 (11%)779 (12%)
Other14 (6%)148 (9%)402 (6%)
ALF0 (0%)2 (0%)22 (0%)
Blood groupO94 (43%)736 (46%)3068 (46%)0.40.3
A81 (38%)614 (38%)2593 (39%)
B27 (13%)204 (13%)752 (11%)
AB13 (6%)60 (4%)249 (4%)
Outcome at 26 November 2018Transplanted172 (80%)1225 (76%)5070 (76%)0.50.4
Died on list19 (9%)171 (11%)585 (9%)
Removed23 (11%)197 (12%)949 (14%)
Still active1 (0%)21 (1%)58 (1%)
Median (IQR)Age (years)57 (49–61)54 (45–60)55 (47–61)0.0020.13
BMI (kg/m2)27.1 (24.4–30.2)26.4 (23.1–30.0)26.9 (23.7–30.9)0.020.6
Serum Na+ (mmol/L)137 (134–140)136 (133–139)137 (134–140)0.020.7
Serum Cr (μmol/L)74.5 (62–91)75 (61–92)76 (62–95)0.80.5
Serum Bili (μmol/L)42 (23–80)43 (23–83)44 (24–87)0.70.4
INR1.4 (1.2–1.6)1.3 (1.2–1.6)1.3 (1.2–1.6)0.70.5
  • Bold text indicates significant results.

  • *Fishers exact or χ2 p values for categorical data and Kruskal-Wallis p values for continuous data (p<0.05 considered statistically significant).

  • AID, autoimmune disease; ALD, alcoholic liver disease; ALF, acute liver failure; Bili, bilirubin; Cr, creatinine; Ex., excluded; HBV, hepatitis B virus; HCV, hepatitis C virus; KCH, King’s College Hospital; Na+, sodium; PBC, primary biliary cirrhosis; PSC, primary sclerosing cholangitis; SWLU, South West Liver Unit.